More from the blog
- About us
- Dementia info
- Living with dementia
- Our scientists
- Our supporters
From traffic accidents to collision sports, millions of people experience head injuries every year. Dr Neil Graham’s latest blog explores the long-term consequences of a head injury and the changes that may lead to an increased risk of dementia.
Alzheimer’s Research UK has spearheaded a new review, calling for a fresh focus on how problems with early memory and thinking should be recognised, diagnosed, and treated
Kayleigh Watts, from Addenbrooke’s Hospital in Cambridge has worked with people with frontotemporal dementia (FTD) and their loved ones during the Covid-19 pandemic. She reflects on the impact of COVID-19 on those with FTD, in a piece originally written for the Psychologist Magazine.
With your support, our scientists are looking closely at how DNA changes contribute to the diseases that cause dementia.
We were proud to partner with actress and broadcaster Shobna Gulati as she released her memoir Remember Me? just ahead of World Alzheimer’s Day in September. Shobna invited us to include an afterword to her book, which she has kindly allowed us to reproduce in full here.
Your support is continuing to fund research like this that will make our mission to bring about a life-changing dementia treatment for people possible.
I’m a consultant at Mattioli Woods, a corporate partner of Alzheimer’s Research UK, and this October, I’ll be running the London Marathon to raise funds for groundbreaking research. Well, virtually anyway!
This October, Alzheimer’s Research UK is teaming up with My Favourite Voucher Codes in their charity poll, and we would love for you to support us.
We were delighted to welcome actress and broadcaster Shobna Gulati to a special event on 16 September to mark the launch of her memoir Remember me?.
Nine months after the devastating loss of his mum to Alzheimer’s, Paul wants to do everything he can to ensure dementia research continues to make progress.
Dr Susan Kohlhaas has joined Alzheimer’s Research UK as our new Director of Research.
We caught up with Dr Meghan Larin, a postdoctoral researcher, and Emma Randall, a research assistant, in Prof Vincent Dion’s lab at the UK DRI at Cardiff University.
This year, the world’s largest dementia research conference – the Alzheimer’s Association International Conference (AAIC) – went virtual. Here are our top seven highlights from the week!
We know that if we can understand what increases the risk of developing dementia, governments and individuals can be better informed about how to reduce that risk.
Times are challenging for everyone at the moment and our dementia researchers are no exception, so now more than ever it’s important to celebrate our scientists’ successes.
Now, as governments across the UK begin to ease restrictions, labs are starting to re-open and research that your support helps to fund is restarting. However, this process is complex and looks different for every lab and region.
There have been many stories in the media over the past few months about COVID-19 and dementia.
This Father’s Day I’ll be lacing up my trainers for Dad and dementia research, and here’s why.
Dementia is thought to affect around 850,000 people in the UK. Most people associate the condition with Alzheimer’s disease, the most common cause of dementia. But there are other diseases that can cause the symptoms of dementia – including frontotemporal dementia (FTD).
Have you heard the news about the partnership between Alzheimer’s Research UK and Tikiboo?
With social fundraising no longer an option, my new working from home environment meant that I had to find a different way to help, and that was to learn more about dementia.
Microscopic images reveal the hidden beauty around and within us. Dementia researchers get a unique view of the intricate but stunning workings of the brain. To showcase the fascinating insights being gained in dementia research, we ran our Science Image Competition again this year.
The COVID-19 Symptom Tracker app, developed by King’s College London, is joining forces with the UK’s largest health-based charities. The aim is to reach people most at risk of COVID-19, including those with pre-existing health conditions such as dementia, diabetes, heart disease and those over the age of 70.